Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.
Read original at benzingaStocks · News reference
BillionToOne Affirms FY2026 Sales Guidance of $450.000M-$465.000M vs $456.440M Est
BillionToOne (NASDAQ:BLLN) affirms FY2026 sales outlook from $450.000 million-$465.000 million to $450.000 million-$465.000 million vs $456.440 million estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:14 PM
- Checked
- Aug 5, 2026, 8:14 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
BillionToOne shares are trading lower after the company reported mixed Q3 financial results. Also, BTIG lowered its price target on the stock from $142 to $130.
Read original at benzingaBTIG Maintains Buy on BillionToOne, Lowers Price Target to $130
BTIG analyst Mark Massaro maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $142 to $130.
Read original at benzingaBillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
BillionToOne stock fell after hours after reporting second-quarter financial results.
Read original at benzinga